摘要
目的:比较艾迪、艾迪联合化疗、化疗治疗老年非霍奇金淋巴瘤的近期疗效和不良反应。方法:艾迪组20例、艾迪联合化疗组19例、化疗组20例;采用CHOP或CVP方案化疗。结果:艾迪组、艾迪注射液联合化疗组、化疗组的有效率(CR+PR)分别为15%、47.3%、40%。结论:艾迪注射液联合化疗效果显著,优于单用艾迪注射液和单用化疗组,为老年淋巴瘤姑息治疗的良好选择。
Objective：To compare the short-term efficacy and adverse reaction among Addie,Addie combined with chemotherapy and chemotherapy for treatment of non-Hodgkin lymphoma in elderly patients.Methods：Different treatments were applied in Addie group of 20 cases,Addie combined with chemotherapy group of 19 and chemotherapy group of 20.Then the short-term efficacy and adverse reaction were observed in all the 3 groups.Results：The effective rate in the Addie group,Addie injection combined with chemotherapy group,chemotherapy group efficiency（CR＋PR） was 15%,47.3% and 40%,respectively.Conclusion：Addie injection combined with chemotherapy has significantly better effect than the single Addie injection and chemotherapy alone groups,which is a good option for palliative treatment of lymphoma in aged patients.
出处
《中国医学装备》
2012年第4期72-73,共2页
China Medical Equipment
关键词
艾迪注射液
化疗
老年淋巴瘤
Addie injection
Chemotherapy
Elderly patients with lymphoma
